| Ytd | -47.22% | |
| 1y | -84.52% |
| Open | 1.27 | Prev Close | 1.35 | Low | 1.04 | High | 1.86 | Mkt Cap | 4.25M |
| Vol | 2.97M | Avg Vol | 224.04K | EPS | -4.73 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 0.60 | Short Ratio | 2.45 | Inst. Own | 1.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.02 | 200-d Avg | 2.49 | 1yr Est | 6.00 |
PCSA News
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 7.8% to $1.52 during Friday's
VERO BEACH, FL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a
Processa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks Transcript
Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's r
Dow Jones falls 800+ pts; energy shares up 2.6%; General Dynamics beats earnings estimates; Verra Mo
US stocks mostly lower, Dow Jones falls 400+ pts. Energy shares up 3%. Procter & Gamble shares d
Processa Pharmaceuticals said on Wednesday it acquired privately held Vidya Therapeutics in an all-s
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday'
Acquisition brings into Processa's pipeline Vidya's lead asset, VT-7208, a next-generation, CNS-pene
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
Heatwurx (NASDAQ: PCSA - Get Free Report) and Stevanato Group (NYSE: STVN - Get Free Report) are bot
Heatwurx (NASDAQ: PCSA - Get Free Report) and Aquestive Therapeutics (NASDAQ: AQST - Get Free Report
VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a
Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIR
Processa Pharmaceuticals stock jumps 122% after a phase II update shows NGC-Cap delivers higher acti
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) stock is skyrocketing on Wednesday, with a session vol
Preliminary Phase 2 data demonstrate PCS6422+Capecitabine increased cancer-killing metabolite exposu
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 Conti
HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “
HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), today
HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a cli
HANOVER, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clin